2020 SIOG建议:老年急性早幼粒细胞白血病的治疗

2020-04-06 国际老年肿瘤学会 J Geriatr Oncol. 2020 Apr 6.

2020年4月,国际老年肿瘤学会(SIOG)发布了老年急性早幼粒细胞白血病的治疗建议,约有1/3的急性早幼粒细胞白血病(APL)的患者年龄超过60岁,确保老年患者得到恰当的诊断和治疗非常重要。本文主要

中文标题:

2020 SIOG建议:老年急性早幼粒细胞白血病的治疗

英文标题:

Treatment of acute promyelocytic leukemia in older patients: recommendations of an International Society of Geriatric Oncology (SIOG) task force

发布机构:

国际老年肿瘤学会

发布日期:

2020-04-06

简要介绍:

2020年4月,国际老年肿瘤学会(SIOG)发布了老年急性早幼粒细胞白血病的治疗建议,约有1/3的急性早幼粒细胞白血病(APL)的患者年龄超过60岁,确保老年患者得到恰当的诊断和治疗非常重要。本文主要针对老年APL患者的治疗提供指导建议,以提高老年患者的诊断、管理和存活率。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 SIOG建议:老年急性早幼粒细胞白血病的治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2d5871c0018960e8, title=2020 SIOG建议:老年急性早幼粒细胞白血病的治疗, enTitle=Treatment of acute promyelocytic leukemia in older patients: recommendations of an International Society of Geriatric Oncology (SIOG) task force, guiderFrom=J Geriatr Oncol. 2020 Apr 6., authorId=0, author=, summary=2020年4月,国际老年肿瘤学会(SIOG)发布了老年急性早幼粒细胞白血病的治疗建议,约有1/3的急性早幼粒细胞白血病(APL)的患者年龄超过60岁,确保老年患者得到恰当的诊断和治疗非常重要。本文主要, cover=https://img.medsci.cn/2020426/1587911907691_2020535.jpg, journalId=0, articlesId=null, associationId=659, associationName=国际老年肿瘤学会, associationIntro=国际老年肿瘤学会成立于2000年,其目标是促进老年肿瘤领域的发展,以优化老年癌症病人的治疗。学会推进该方面的培训、科研和政策等以支持其宗旨。SIOG是一个多学科的学会,包括肿瘤学和老年医学,其会员遍及四十多个国家。, copyright=0, guiderPublishedTime=Mon Apr 06 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年4月,国际老年肿瘤学会(SIOG)发布了老年急性早幼粒细胞白血病的治疗建议,约有1/3的急性早幼粒细胞白血病(APL)的患者年龄超过60岁,确保老年患者得到恰当的诊断和治疗非常重要。本文主要针对老年APL患者的治疗提供指导建议,以提高老年患者的诊断、管理和存活率。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=3204, tagName=急性早幼粒细胞白血病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3204, guiderKeyword=急性早幼粒细胞白血病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4997, appHits=174, showAppHits=36, pcHits=1758, showPcHits=4749, likes=1, shares=7, comments=4, approvalStatus=1, publishedTime=Sun Apr 26 23:10:10 CST 2020, publishedTimeString=2020-04-06, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Apr 26 22:38:31 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 19:20:22 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 SIOG建议:老年急性早幼粒细胞白血病的治疗.pdf)])
2020 SIOG建议:老年急性早幼粒细胞白血病的治疗.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1050100, encodeId=cd221050100e7, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75e35598373, createdName=ms7000000153400245, createdTime=Mon Sep 13 23:37:39 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009758, encodeId=0fab1009e58d3, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7e12388756, createdName=xiaomilu, createdTime=Fri Aug 20 16:28:11 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924852, encodeId=417a92485265, content=很不错的!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/07/22ed8d27f51c09614414ed69fa316652.jpg, createdBy=f3db5259044, createdName=147fa89am84(暂无昵称), createdTime=Tue Feb 16 09:02:22 CST 2021, time=2021-02-16, status=1, ipAttribution=)]
    2021-09-13 ms7000000153400245

    不错

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1050100, encodeId=cd221050100e7, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75e35598373, createdName=ms7000000153400245, createdTime=Mon Sep 13 23:37:39 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009758, encodeId=0fab1009e58d3, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7e12388756, createdName=xiaomilu, createdTime=Fri Aug 20 16:28:11 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924852, encodeId=417a92485265, content=很不错的!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/07/22ed8d27f51c09614414ed69fa316652.jpg, createdBy=f3db5259044, createdName=147fa89am84(暂无昵称), createdTime=Tue Feb 16 09:02:22 CST 2021, time=2021-02-16, status=1, ipAttribution=)]
    2021-08-20 xiaomilu

    学习了!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1050100, encodeId=cd221050100e7, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75e35598373, createdName=ms7000000153400245, createdTime=Mon Sep 13 23:37:39 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009758, encodeId=0fab1009e58d3, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7e12388756, createdName=xiaomilu, createdTime=Fri Aug 20 16:28:11 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924852, encodeId=417a92485265, content=很不错的!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/07/22ed8d27f51c09614414ed69fa316652.jpg, createdBy=f3db5259044, createdName=147fa89am84(暂无昵称), createdTime=Tue Feb 16 09:02:22 CST 2021, time=2021-02-16, status=1, ipAttribution=)]
    2021-02-16 147fa89am84(暂无昵称)

    很不错的!

    0